Ergoteles’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-502
Closed -$3.86K 2022
2022
Q4
$3.86K Buy
+502
New +$5.8K ﹤0.01% 1389
2021
Q4
Sell
-939
Closed -$304K 1805
2021
Q3
$304K Sell
939
-20
-2% -$6.22K 0.01% 791
2021
Q2
$337K Buy
+959
New +$314K 0.01% 1014

Other funds holding CFRX

Ergoteles's CFRX Position: Q1 2023 in Review

Ergoteles sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 502 shares — an estimated $3.86K sold.

Ergoteles first reported a position in CFRX in Q2 2021 and held it in 3 quarters. The position peaked at $337K in Q2 2021. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

  • Ergoteles reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 502 ContraFect Corporation shares in Q1 2023, an estimated $3.86K.
  • Ergoteles first reported a position in ContraFect Corporation in Q2 2021 and held it in 3 quarters.
  • Ergoteles's ContraFect Corporation position peaked at $337K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.